Diabetic Nephropathy

Journal of the American Society of Nephrology

Volumn 8, Issue 3, 1997, Pages 487-493

  Ibrahim, Hassan N ^a   Hostetter, Thomas H ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIABETIC NEPHROPATHY; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; HUMANS; INCIDENCE; RISK FACTORS;

EID: 0031093818     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. United States Renal Data System: USRDS Annual Data Report. Bethesda, MD, The National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, July 1994
2. Hostetter TH: Pathogenesis and treatment of diabetic nephropathy. Adv Endocrinol Metab 2: 221-248, 1991
3. Hostetter TH: Diabetic nephropathy: Metabolic versus hemodynamics. Diabetes Care 15: 1205-1215, 1992
4. Mogensen CE, Anderson MJF: Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 22: 706-713, 1973
5. Parving HH, Rossig P, Hommel E and Smidt UM: Angiotensin-converting enzyme inhibition in diabetic nephropathy: Ten years' experience. In: Renal Disease Progression and Management, edited by Aurum M, Klahr S, Philadelphia, W.B. Saunders, 1996, 58-66
6. Klein R, Klein B, Moss S: Incidence of gross proteinuria in older-onset diabetes. Diabetes 42: 381-389, 1993
7. Nelson R, Bennett P, Beck G, Tan M, Knowler W, Mitch W, Hirschman G, Myers B: Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. N Engl J Med 335: 1636-1642, 1996
8. Grenfell A, Watkins PJ: Clinical diabetic nephropathy: Natural history and complications. Clin Endocrinol Metab 15: 783-805, 1986
9. Gall MA, Nielsen FS, Smidt UM, Parving HH: The course of kidney function in Type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia 36: 1071-1078, 1993
10. Parving HH, Hommel E, Mathiesen ER, Skott P, Edsberg B, Bahnsen M, Lauritzen M, Hougaard P, Lauritzen E: Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin-dependent diabetes. Br Med J 296: 156-160, 1988
11. Trevisan R, Nosadini R, Fioretto P, et al: Clustering of risk factors in hypertensive insulin-dependent diabetics with high sodium-lithium countertransport. Kidney Int 41: 855-861, 1992
12. O'Bryan GT, Hostetter TH: The renal hemodynamic basis of diabetic nephropathy. Semin Nephrol, in press
13. Hostetter TH, Rennke HG, Brenner BM: The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 318: 140-145, 1988
14. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993
15. Boel E, Selmer J, Flodguard, Jensen T: Diabetic late complications: Will aldose reductase inhibitors or advanced glycosylation end product formation hold promise? J Diabetes Comp 9: 104-129, 1995
16. Brownlee M, Pongor S, Cerami A: Covalent attachment of soluble proteins by nonenzymatically glycosylated collagen. J Exp Med 158: 1739-1744, 1983
17. Chodhury TA, Kumar S, Burnett AH, Bain SC: Nephropathy in type I diabetes: The role of genetic factors. Diabetic Med 12: 1059-1067, 1995
18. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease: Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320: 1161-1165, 1989
19. O'Hare JA, Rolan JM, Walters G, Corrall RJ: Impaired sodium excretion in response to volume expansion induced by water immersion in non-insulin dependent diabetes mellitus. Clin Sci 71: 403-409, 1986
20. Drury PL, Smith GM, Ferris GB: Increased vasopressor responsiveness to angiotensin II in type I (insulin dependent) diabetic patients without complications. Diabetologia 27: 174-179, 1984
21. Parving HH, Jacobsen P, Tarnow L, Rossig P, Lecerf L, Poirier O, Cambien F: Effect of deletion polymorphism of angiotension converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotension converting enzyme: Observational follow up study. Br Med J 313: 591-594, 1996
22. Ritz E, Stefanski A: Diabetic nephropathy in type II diabetes. Am J Kidney Dis 27: 167-194, 1996
23. Olsen D: Light microscopy of diabetic glomerulosclerosis: Classic lesions and differential diagnosis. In: The Kidney and Hypertension in Diabetes Mellitus, edited by Mogensen CE, Boston, Martinus Nijhoff Publishing, 1988, p 71
24. Lewis EJ, Hunsicker LG, Bain RP, Rhode RD: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy: The Collaborative Study Group. N Engl J Med 329: 1456-1462, 1993
25. Mathiesen ER, Hommel E, Giese J, Parving HH: Efficacy of captopril in postponing nephropathy in normotensive insulin-dependent diabetic patients with microalbuminuria. BMJ 303: 81-87, 1991
26. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M: Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 118: 577-581, 1993
27. Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T: Coronary artery disease in young type I (insulin-dependent) diabetic patients with and without diabetic nephropathy: Incidence and risk factors. Diabetologia 30: 144-148, 1987
28. Manske CL: End-stage renal therapy in diabetic nephropathy. In: The Principles and Practice of Nephrology, 2nd Ed., edited by Jacobson H, Striker G, Klahr S, St. Louis, Mosby, 1995, pp 345-351
29. Maiorca R, Vonesh EF, Cavalli P, DeVecchi A, Giangrande A, Le Greca G, Scarpioni LL, Bragantini L, Cancarini GC, Cantaluppi A: A multicenter, selection-adjusted comparison of patient and technique survival on CAPD and hemodialysis. Perit Dial Int 11: 118, 1991
30. Manske CL, Thomas W, Wang Y, Wilson RF: Screening diabetic transplant candidates for coronary artery disease: Identification of a low-risk group. Kidney Int 44: 617-621, 1993
31. Manske CL, Wang Y, Wilson RF, et al: Coronary revascularization in type I diabetic patients with nephropathy. Lancet 340: 998-1002, 1992
32. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators: Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 335: 217-225, 1996
33. Manske CL, Wang Y, Thomas W: Mortality of cadaveric kidney transplantation versus combined kidney-pancreas transplantation in diabetic patients. Lancet 346: 658-1662, 1995